Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma.
The post Lilly’s Chief Information & Digital Officer: AI Use Goes Far Beyond Just Drug Discovery appeared first on MedCity News.
